1500005I dynport vaccine company, LLC; phase 1 clinical trials units for therapeutics against infectious diseases; to 16-0003.B1.0059--05 base task order funding; biod can 8470038; $222,661
Ended Awarded Last action
- Contract number
- HHSN27200005
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755 Part of General Dynamics Corp
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $215,681
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $215,681.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$6,980 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Original award | $222,661 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The $222,661 award is a delivery order under the Therapeutics Against Infectious Diseases Phase 1 IDIQ contract, which funds Phase 1 clinical trials for therapeutics against infectious diseases. The contract does not have a set-aside designation. This order is for Dynport to conduct Phase 1 clinical trials for therapeutics against infectious diseases. Dynport has previously provided preclinical development, clinical trials, diagnostics, and manufacturing services to federal agencies like NIAID and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under various prime contracts and subcontracts.
Quick answers
Who was awarded contract HHSN27200005?
HHSN27200005 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 2, 2017.
How much is contract HHSN27200005 worth?
The government has obligated $215,681 on HHSN27200005.
Is contract HHSN27200005 an order under another contract?
Yes. HHSN27200005 is a delivery order under HHSN272201500005I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract HHSN27200005 competed?
The extent of competition for HHSN27200005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award